Last10K.com

Q Biomed Inc. (QBIO) SEC Filing 10-Q Quarterly Report for the period ending Tuesday, February 28, 2023

SEC Filings

QBIO Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

QBIO Annual Reports

QBIO Quarterly Reports

QBIO Corporate News

QBIO Registration of Securities

Q Biomed Inc.

HISTORY TOOLS
CIK: 1596062 Ticker: QBIO

View differences made from one quarter to another to evaluate Q Biomed Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Q Biomed Inc..

Continue

Assess how Q Biomed Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Q Biomed Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: QBIO
CIK: 1596062
Form Type: 10-Q Quarterly Report
Accession Number: 0001410578-23-001445
Submitted to the SEC: Fri Jun 16 2023 4:00:19 PM EST
Accepted by the SEC: Fri Jun 16 2023
Period: Tuesday, February 28, 2023
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/qbio/0001410578-23-001445.htm